Interesante, no los conocia como tal , tal vez muchos de uds aqui si.
------------
Try This ETF Pair To Round Out Your Biotech Exposure
Mar. 15, 2018 6:36 PM ET
Summary
If you're using funds, such as IBB and BBH, for biotech exposure in your portfolio, you're mostly investing in the industry's biggest names.
IBB has nearly 30% of its assets invested in the big 4 biotech companies - Gilead, Biogen, Amgen and Celgene.
Equal weighting the biotech sector might be a better way to balance out risk and improve returns.
I propose using a pair of equal-weight biotech ETFs in place of IBB.
Dave Dierking, CFA
ETF investing, portfolio strategy, dividend investing, retirement
The
Virtus LifeSci Biotech Products ETF (
BBP) and the
Virtus LifeSci Biotech Clinical Trials ETF (
BBC) essentially split the biotech universe into two groups.
BBP invests in products stage companies. They have already successfully completed multiple human clinical trials and have received FDA approval to sell and market a drug.
BBC invests in clinical trials stage companies. These companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drug candidates in human clinical trials.
https://seekingalpha.com/article/4156921-try-etf-pair-round-biotech-exposure